company background image
A950130

Access Bio KOSDAQ:A950130 Stock Report

Last Price

₩11.45k

Market Cap

₩386.6b

7D

-3.9%

1Y

0.9%

Updated

26 Sep, 2023

Data

Company Financials

A950130 Stock Overview

Access Bio, Inc. engages in the research, development, and manufacture of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products worldwide.

A950130 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health5/6
Dividends2/6

Access Bio, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Access Bio
Historical stock prices
Current Share Price₩11,450.00
52 Week High₩14,700.00
52 Week Low₩7,180.00
Beta0.26
1 Month Change42.24%
3 Month Change42.95%
1 Year Change0.88%
3 Year Change-50.65%
5 Year Change144.66%
Change since IPO10.63%

Recent News & Updates

Recent updates

Access Bio's (KOSDAQ:950130) Earnings Are Weaker Than They Seem

Mar 26
Access Bio's (KOSDAQ:950130) Earnings Are Weaker Than They Seem

Is Access Bio (KOSDAQ:950130) A Risky Investment?

Mar 25
Is Access Bio (KOSDAQ:950130) A Risky Investment?

If You Had Bought Access Bio (KOSDAQ:950130) Shares A Year Ago You'd Have Earned 740% Returns

Feb 18
If You Had Bought Access Bio (KOSDAQ:950130) Shares A Year Ago You'd Have Earned 740% Returns

Shareholder Returns

A950130KR Medical EquipmentKR Market
7D-3.9%-5.2%-3.5%
1Y0.9%17.7%13.9%

Return vs Industry: A950130 underperformed the KR Medical Equipment industry which returned 17.7% over the past year.

Return vs Market: A950130 underperformed the KR Market which returned 13.9% over the past year.

Price Volatility

Is A950130's price volatile compared to industry and market?
A950130 volatility
A950130 Average Weekly Movement11.4%
Medical Equipment Industry Average Movement7.5%
Market Average Movement6.0%
10% most volatile stocks in KR Market12.3%
10% least volatile stocks in KR Market3.2%

Stable Share Price: A950130 is more volatile than 75% of KR stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: A950130's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
200293Young-Ho Choihttps://accessbio.net

Access Bio, Inc. engages in the research, development, and manufacture of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products worldwide. The company was founded in 2002 and is headquartered in Somerset, New Jersey.

Access Bio, Inc. Fundamentals Summary

How do Access Bio's earnings and revenue compare to its market cap?
A950130 fundamental statistics
Market Cap₩386.57b
Earnings (TTM)₩8.26b
Revenue (TTM)₩398.05b

46.8x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
A950130 income statement (TTM)
Revenue₩398.05b
Cost of Revenue₩159.06b
Gross Profit₩238.99b
Other Expenses₩230.73b
Earnings₩8.26b

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)244.60
Gross Margin60.04%
Net Profit Margin2.07%
Debt/Equity Ratio3.9%

How did A950130 perform over the long term?

See historical performance and comparison

Dividends

7.2%

Current Dividend Yield

339%

Payout Ratio